
2025-2031 Global Prenatal Second-Generation DNA Sequencing Industry Research & Trends Analysis Report
The research report on ‘Prenatal Second-Generation DNA Sequencing Market’ provides a workplan for stakeholders for the estimated timeframe of 2025-2031. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Prenatal Second-Generation DNA Sequencing Market Overview
Prenatal second-generation DNA sequencing refers to the cutting-edge prenatal screening method that uses high-throughput sequencing technology to analyze fetal free DNA in the peripheral blood of pregnant women, in order to detect fetal chromosomal abnormalities and genetic diseases. Compared to invasive examinations such as amniocentesis, this method has significant advantages of non invasiveness and high safety. In terms of clinical application, prenatal second-generation DNA sequencing has expanded from the initial screening for Down syndrome to include screening for sex chromosome abnormalities (such as Turner syndrome, Klinefelter syndrome), microdeletion/microduplication syndrome (such as 22q11.2 deletion syndrome), and some monogenic genetic diseases.
Key Insights & Strategic Takeaways Driving Market Outlook
(1) Global Prenatal Second-Generation DNA Sequencing market size (sales volume & revenue), history data from 2020 - 2025, and forecast data from {2025 to 2031.
(2) Global Prenatal Second-Generation DNA Sequencing market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.
(3) China Prenatal Second-Generation DNA Sequencing market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.
(4) Global Prenatal Second-Generation DNA Sequencing segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.
(5) Global Prenatal Second-Generation DNA Sequencing segment by Type, and by Application, and regional segment by Type, and by Application.
(6) Global major production regions of Prenatal Second-Generation DNA Sequencing , capacity, production and trends.
(7) Prenatal Second-Generation DNA Sequencing industry supply chain, upstream, midstream, and downstream analysis.
In-Depth Assessment of Market Segmentation by Geographic Region
➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)
Segmentation by Product Type: Analytical Breakdown and Market Relevance
This section presents a comprehensive analysis of the market based on product type, highlighting segment-wise performance indicators, emerging trends, and their strategic implications within the overall industry landscape.
- High-Risk Pregnant Women Screening
- Twin Pregnancy
- Assisted Reproductive Technology Pregnancy
- Low-Risk Pregnant Women Screening
- Others
Market Segmentation by Application
Markets are categorized based on specific application areas, offering insight into usage trends and consumer preferences. This segmentation helps businesses tailor products, services, and strategies to align with diverse industry needs and customer demands.
- Genome Sequencing
- Targeted Sequencing
Market Segmentation by Key Players
This report examines the competitive landscape by categorizing market participants based on their roles, influence, and strategic positioning. Understanding player segmentation helps identify industry leaders, emerging competitors, and collaboration opportunities within the market.
- Roche
- Natera
- Illumina
- Quest Diagnostics
- Ambry Genetics
- PerkinEImer
- Invitae
- Neogenomics
- Agilent Technologies
- Sema4
- Thermo Fisher Scientific
- Fulgent Genetics
- Genomics England
- BGI Genomics
- Berry Genomics
- DAAN Gene
- CapitalBio
- Annoroad
- MGI Tech
- FANdi Biotechnology
- BioMiao Biotechnology
- JBP Medical
1 Market Overview
1.1 Product Overview and Scope of Prenatal Second-Generation DNA Sequencing
1.2 Global Prenatal Second-Generation DNA Sequencing Market Size and Forecast
1.3 China Prenatal Second-Generation DNA Sequencing Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Prenatal Second-Generation DNA Sequencing Share in Global Market, 2020-2031
1.4.2 Prenatal Second-Generation DNA Sequencing Market Size: China VS Global, 2020-2031
1.5 Prenatal Second-Generation DNA Sequencing Market Dynamics
1.5.1 Prenatal Second-Generation DNA Sequencing Market Drivers
1.5.2 Prenatal Second-Generation DNA Sequencing Market Restraints
1.5.3 Prenatal Second-Generation DNA Sequencing Industry Trends
1.5.4 Prenatal Second-Generation DNA Sequencing Industry Policy
2 Competitive Landscape by Company
2.1 Global Prenatal Second-Generation DNA Sequencing Revenue by Company, 2020-2025
2.2 Global Prenatal Second-Generation DNA Sequencing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Prenatal Second-Generation DNA Sequencing Concentration Ratio
2.4 Global Prenatal Second-Generation DNA Sequencing Mergers & Acquisitions, Expansion Plans
2.5 Global Prenatal Second-Generation DNA Sequencing Manufacturers Product Type
2.6 Global Geographic Distribution of Prenatal Second-Generation DNA Sequencing Companies
3 China Competitive Situation by Company
3.1 China Prenatal Second-Generation DNA Sequencing Revenue by Company, 2020-2025
3.2 China Prenatal Second-Generation DNA Sequencing Prenatal Second-Generation DNA Sequencing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Prenatal Second-Generation DNA Sequencing Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
4.1 Prenatal Second-Generation DNA Sequencing Industry Chain
4.2 Prenatal Second-Generation DNA Sequencing Upstream Analysis
4.3 Prenatal Second-Generation DNA Sequencing Midstream Analysis
4.4 Prenatal Second-Generation DNA Sequencing Downstream Analysis
5 Sights by Type
5.1 Prenatal Second-Generation DNA Sequencing Classification
5.1.1 Genome Sequencing
5.1.2 Targeted Sequencing
5.2 by Type, Global Prenatal Second-Generation DNA Sequencing Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
6 Sights by Application
6.1 Prenatal Second-Generation DNA Sequencing Segment by Application
6.1.1 High-Risk Pregnant Women Screening
6.1.2 Twin Pregnancy
6.1.3 Assisted Reproductive Technology Pregnancy
6.1.4 Low-Risk Pregnant Women Screening
6.1.5 Others
6.2 by Application, Global Prenatal Second-Generation DNA Sequencing Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
7 Sights by Region
7.1 By Region, Global Prenatal Second-Generation DNA Sequencing Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
7.3 North America
7.3.1 North America Prenatal Second-Generation DNA Sequencing Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Prenatal Second-Generation DNA Sequencing Market Size Market Share
7.4 Europe
7.4.1 Europe Prenatal Second-Generation DNA Sequencing Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Prenatal Second-Generation DNA Sequencing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Prenatal Second-Generation DNA Sequencing Market Size Market Share
7.6 South America
7.6.1 South America Prenatal Second-Generation DNA Sequencing Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Prenatal Second-Generation DNA Sequencing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Prenatal Second-Generation DNA Sequencing Market Size & CAGR,2020 VS 2024 VS 2031
8.2 By Country, Global Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.3 United States
8.3.1 United States Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.3.2 By Company, United States Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.3.3 by Type, United States Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.4.2 By Company, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.4.3 by Type, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.5.2 By Company, China Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.5.3 by Type, China Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.6.2 By Company, Japan Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.6.3 by Type, Japan Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.7.2 By Company, South Korea Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.7.3 by Type, South Korea Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.9.2 By Company, India Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.9.3 by Type, India Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Prenatal Second-Generation DNA Sequencing Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
9 Company Profile
9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area, and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.1.4 Roche Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.1.5 Roche Recent Developments
9.2 Natera
9.2.1 Natera Company Information, Head Office, Market Area, and Industry Position
9.2.2 Natera Company Profile and Main Business
9.2.3 Natera Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.2.4 Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.2.5 Natera Recent Developments
9.3 Illumina
9.3.1 Illumina Company Information, Head Office, Market Area, and Industry Position
9.3.2 Illumina Company Profile and Main Business
9.3.3 Illumina Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.3.4 Illumina Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.3.5 Illumina Recent Developments
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.4.2 Quest Diagnostics Company Profile and Main Business
9.4.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.4.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.4.5 Quest Diagnostics Recent Developments
9.5 Ambry Genetics
9.5.1 Ambry Genetics Company Information, Head Office, Market Area, and Industry Position
9.5.2 Ambry Genetics Company Profile and Main Business
9.5.3 Ambry Genetics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.5.4 Ambry Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.5.5 Ambry Genetics Recent Developments
9.6 PerkinEImer
9.6.1 PerkinEImer Company Information, Head Office, Market Area, and Industry Position
9.6.2 PerkinEImer Company Profile and Main Business
9.6.3 PerkinEImer Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.6.4 PerkinEImer Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.6.5 PerkinEImer Recent Developments
9.7 Invitae
9.7.1 Invitae Company Information, Head Office, Market Area, and Industry Position
9.7.2 Invitae Company Profile and Main Business
9.7.3 Invitae Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.7.4 Invitae Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.7.5 Invitae Recent Developments
9.8 Neogenomics
9.8.1 Neogenomics Company Information, Head Office, Market Area, and Industry Position
9.8.2 Neogenomics Company Profile and Main Business
9.8.3 Neogenomics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.8.4 Neogenomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.8.5 Neogenomics Recent Developments
9.9 Agilent Technologies
9.9.1 Agilent Technologies Company Information, Head Office, Market Area, and Industry Position
9.9.2 Agilent Technologies Company Profile and Main Business
9.9.3 Agilent Technologies Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.9.4 Agilent Technologies Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.9.5 Agilent Technologies Recent Developments
9.10 Sema4
9.10.1 Sema4 Company Information, Head Office, Market Area, and Industry Position
9.10.2 Sema4 Company Profile and Main Business
9.10.3 Sema4 Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.10.4 Sema4 Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.10.5 Sema4 Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
9.11.2 Thermo Fisher Scientific Company Profile and Main Business
9.11.3 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.11.4 Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.11.5 Thermo Fisher Scientific Recent Developments
9.12 Fulgent Genetics
9.12.1 Fulgent Genetics Company Information, Head Office, Market Area, and Industry Position
9.12.2 Fulgent Genetics Company Profile and Main Business
9.12.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.12.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.12.5 Fulgent Genetics Recent Developments
9.13 Genomics England
9.13.1 Genomics England Company Information, Head Office, Market Area, and Industry Position
9.13.2 Genomics England Company Profile and Main Business
9.13.3 Genomics England Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.13.4 Genomics England Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.13.5 Genomics England Recent Developments
9.14 BGI Genomics
9.14.1 BGI Genomics Company Information, Head Office, Market Area, and Industry Position
9.14.2 BGI Genomics Company Profile and Main Business
9.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.14.5 BGI Genomics Recent Developments
9.15 Berry Genomics
9.15.1 Berry Genomics Company Information, Head Office, Market Area, and Industry Position
9.15.2 Berry Genomics Company Profile and Main Business
9.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.15.5 Berry Genomics Recent Developments
9.16 DAAN Gene
9.16.1 DAAN Gene Company Information, Head Office, Market Area, and Industry Position
9.16.2 DAAN Gene Company Profile and Main Business
9.16.3 DAAN Gene Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.16.4 DAAN Gene Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.16.5 DAAN Gene Recent Developments
9.17 CapitalBio
9.17.1 CapitalBio Company Information, Head Office, Market Area, and Industry Position
9.17.2 CapitalBio Company Profile and Main Business
9.17.3 CapitalBio Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.17.4 CapitalBio Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.17.5 CapitalBio Recent Developments
9.18 Annoroad
9.18.1 Annoroad Company Information, Head Office, Market Area, and Industry Position
9.18.2 Annoroad Company Profile and Main Business
9.18.3 Annoroad Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.18.4 Annoroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.18.5 Annoroad Recent Developments
9.19 MGI Tech
9.19.1 MGI Tech Company Information, Head Office, Market Area, and Industry Position
9.19.2 MGI Tech Company Profile and Main Business
9.19.3 MGI Tech Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.19.4 MGI Tech Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.19.5 MGI Tech Recent Developments
9.20 FANdi Biotechnology
9.20.1 FANdi Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.20.2 FANdi Biotechnology Company Profile and Main Business
9.20.3 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.20.4 FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.20.5 FANdi Biotechnology Recent Developments
9.21 BioMiao Biotechnology
9.21.1 BioMiao Biotechnology Company Information, Head Office, Market Area, and Industry Position
9.21.2 BioMiao Biotechnology Company Profile and Main Business
9.21.3 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.21.4 BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.21.5 BioMiao Biotechnology Recent Developments
9.22 JBP Medical
9.22.1 JBP Medical Company Information, Head Office, Market Area, and Industry Position
9.22.2 JBP Medical Company Profile and Main Business
9.22.3 JBP Medical Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
9.22.4 JBP Medical Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, 2020-2025
9.22.5 JBP Medical Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Prenatal Second-Generation DNA Sequencing Market Size & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Prenatal Second-Generation DNA Sequencing Market Restraints
Table 3. Prenatal Second-Generation DNA Sequencing Market Trends
Table 4. Prenatal Second-Generation DNA Sequencing Industry Policy
Table 5. Global Prenatal Second-Generation DNA Sequencing Revenue by Company, 2020-2025, US$ million
Table 6. Global Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company, 2020-2025
Table 7. Global Prenatal Second-Generation DNA Sequencing Players Market Concentration Ratio (CR3 and HHI)
Table 8. Global Prenatal Second-Generation DNA Sequencing Mergers & Acquisitions, Expansion Plans
Table 9. Global Prenatal Second-Generation DNA Sequencing Manufacturers Product Type
Table 10. Global Headquarters and Manufacturing Base of Prenatal Second-Generation DNA Sequencing Manufacturers
Table 11. China Prenatal Second-Generation DNA Sequencing Revenue by Company, 2020-2025, US$ million
Table 12. China Prenatal Second-Generation DNA Sequencing Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Prenatal Second-Generation DNA Sequencing Upstream (Raw Materials)
Table 14. Global Prenatal Second-Generation DNA Sequencing Typical Customers
Table 15. by Type, Global Prenatal Second-Generation DNA Sequencing Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 16. by Application, Global Prenatal Second-Generation DNA Sequencing Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. By Region, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020-2025, US$ Million
Table 19. By Region, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Table 20. By Country, Global Prenatal Second-Generation DNA Sequencing Revenue & CAGR,2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020-2025, US$ Million
Table 22. By Country, Global Prenatal Second-Generation DNA Sequencing Revenue, 2026-2031, US$ Million
Table 23. By Country, Global Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2020-2025
Table 24. By Country, Global Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2026-2031
Table 25. Roche Company Information, Head Office, Market Area, and Industry Position
Table 26. Roche Company Profile and Main Business
Table 27. Roche Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 28. Roche Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 29. Roche Recent Developments
Table 30. Natera Company Information, Head Office, Market Area, and Industry Position
Table 31. Natera Company Profile and Main Business
Table 32. Natera Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 33. Natera Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 34. Natera Recent Developments
Table 35. Illumina Company Information, Head Office, Market Area, and Industry Position
Table 36. Illumina Company Profile and Main Business
Table 37. Illumina Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 38. Illumina Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 39. Illumina Recent Developments
Table 40. Quest Diagnostics Company Information, Head Office, Market Area, and Industry Position
Table 41. Quest Diagnostics Company Profile and Main Business
Table 42. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 43. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 44. Quest Diagnostics Recent Developments
Table 45. Ambry Genetics Company Information, Head Office, Market Area, and Industry Position
Table 46. Ambry Genetics Company Profile and Main Business
Table 47. Ambry Genetics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 48. Ambry Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 49. Ambry Genetics Recent Developments
Table 50. PerkinEImer Company Information, Head Office, Market Area, and Industry Position
Table 51. PerkinEImer Company Profile and Main Business
Table 52. PerkinEImer Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 53. PerkinEImer Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 54. PerkinEImer Recent Developments
Table 55. Invitae Company Information, Head Office, Market Area, and Industry Position
Table 56. Invitae Company Profile and Main Business
Table 57. Invitae Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 58. Invitae Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 59. Invitae Recent Developments
Table 60. Neogenomics Company Information, Head Office, Market Area, and Industry Position
Table 61. Neogenomics Company Profile and Main Business
Table 62. Neogenomics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 63. Neogenomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 64. Neogenomics Recent Developments
Table 65. Agilent Technologies Company Information, Head Office, Market Area, and Industry Position
Table 66. Agilent Technologies Company Profile and Main Business
Table 67. Agilent Technologies Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 68. Agilent Technologies Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 69. Agilent Technologies Recent Developments
Table 70. Sema4 Company Information, Head Office, Market Area, and Industry Position
Table 71. Sema4 Company Profile and Main Business
Table 72. Sema4 Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 73. Sema4 Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 74. Sema4 Recent Developments
Table 75. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
Table 76. Thermo Fisher Scientific Company Profile and Main Business
Table 77. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 78. Thermo Fisher Scientific Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 79. Thermo Fisher Scientific Recent Developments
Table 80. Fulgent Genetics Company Information, Head Office, Market Area, and Industry Position
Table 81. Fulgent Genetics Company Profile and Main Business
Table 82. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 83. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 84. Fulgent Genetics Recent Developments
Table 85. Genomics England Company Information, Head Office, Market Area, and Industry Position
Table 86. Genomics England Company Profile and Main Business
Table 87. Genomics England Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 88. Genomics England Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 89. Genomics England Recent Developments
Table 90. BGI Genomics Company Information, Head Office, Market Area, and Industry Position
Table 91. BGI Genomics Company Profile and Main Business
Table 92. BGI Genomics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 93. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 94. BGI Genomics Recent Developments
Table 95. Berry Genomics Company Information, Head Office, Market Area, and Industry Position
Table 96. Berry Genomics Company Profile and Main Business
Table 97. Berry Genomics Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 98. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 99. Berry Genomics Recent Developments
Table 100. DAAN Gene Company Information, Head Office, Market Area, and Industry Position
Table 101. DAAN Gene Company Profile and Main Business
Table 102. DAAN Gene Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 103. DAAN Gene Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 104. DAAN Gene Recent Developments
Table 105. CapitalBio Company Information, Head Office, Market Area, and Industry Position
Table 106. CapitalBio Company Profile and Main Business
Table 107. CapitalBio Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 108. CapitalBio Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 109. CapitalBio Recent Developments
Table 110. Annoroad Company Information, Head Office, Market Area, and Industry Position
Table 111. Annoroad Company Profile and Main Business
Table 112. Annoroad Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 113. Annoroad Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 114. Annoroad Recent Developments
Table 115. MGI Tech Company Information, Head Office, Market Area, and Industry Position
Table 116. MGI Tech Company Profile and Main Business
Table 117. MGI Tech Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 118. MGI Tech Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 119. MGI Tech Recent Developments
Table 120. FANdi Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 121. FANdi Biotechnology Company Profile and Main Business
Table 122. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 123. FANdi Biotechnology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 124. FANdi Biotechnology Recent Developments
Table 125. BioMiao Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 126. BioMiao Biotechnology Company Profile and Main Business
Table 127. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 128. BioMiao Biotechnology Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 129. BioMiao Biotechnology Recent Developments
Table 130. JBP Medical Company Information, Head Office, Market Area, and Industry Position
Table 131. JBP Medical Company Profile and Main Business
Table 132. JBP Medical Prenatal Second-Generation DNA Sequencing Models, Specifications, and Application
Table 133. JBP Medical Prenatal Second-Generation DNA Sequencing Revenue and Gross Margin, US$ Million, 2020-2025
Table 134. JBP Medical Recent Developments
List of Figures
Figure 1. Prenatal Second-Generation DNA Sequencing Picture
Figure 2. Global Prenatal Second-Generation DNA Sequencing Revenue and Forecast, 2020-2031, US$ Million
Figure 3. China Prenatal Second-Generation DNA Sequencing Revenue and Forecast, 2020-2031, US$ Million
Figure 4. By Revenue, China Prenatal Second-Generation DNA Sequencing Share of Global Market, 2020-2031
Figure 5. Global Prenatal Second-Generation DNA Sequencing Key Participants, Market Share, 2023 VS 2024 VS 2025
Figure 6. Global Prenatal Second-Generation DNA Sequencing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 7. China Prenatal Second-Generation DNA Sequencing Key Participants, Market Share, 2023 VS 2024 VS 2025
Figure 8. China Prenatal Second-Generation DNA Sequencing Key Participants, Market Share, 2024
Figure 9. China Prenatal Second-Generation DNA Sequencing Revenue, Domestic VS Import Products, Proportion of China Local Companies and Foreign Companies, 2020-2031
Figure 10. Prenatal Second-Generation DNA Sequencing Industry Chain
Figure 11. Genome Sequencing
Figure 12. Targeted Sequencing
Figure 13. by Type, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 14. by Type, Global Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2020-2031
Figure 15. High-Risk Pregnant Women Screening
Figure 16. Twin Pregnancy
Figure 17. Assisted Reproductive Technology Pregnancy
Figure 18. Low-Risk Pregnant Women Screening
Figure 19. Others
Figure 20. by Application, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 21. by Application, Global Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2020-2031
Figure 22. By Region, Global Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 23. By Region, Global Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2020-2031
Figure 24. North America Prenatal Second-Generation DNA Sequencing Revenue & Forecasts, 2020-2031, US$ Million
Figure 25. By Country, North America Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 26. Europe Prenatal Second-Generation DNA Sequencing Revenue & Forecasts, 2020-2031, US$ Million
Figure 27. By Country, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 28. Asia Pacific Prenatal Second-Generation DNA Sequencing Revenue & Forecasts, 2020-2031, US$ Million
Figure 29. By Country/Region, Asia Pacific Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 30. South America Prenatal Second-Generation DNA Sequencing Revenue & Forecasts, 2020-2031, US$ Million
Figure 31. By Country, South America Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 32. Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue & Forecasts, 2020-2031, US$ Million
Figure 33. United States Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 34. By Company, United States Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 35. by Type, United States Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 36. by Application, United States Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 37. Europe Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 38. By Company, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 39. by Type, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 40. by Application, Europe Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 41. China Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 42. By Company, China Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 43. by Type, China Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 44. by Application, China Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 45. Japan Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 46. By Company, Japan Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 47. by Type, Japan Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 48. by Application, Japan Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 49. South Korea Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 50. By Company, South Korea Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 51. by Type, South Korea Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 52. by Application, South Korea Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 53. Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 54. By Company, Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 55. by Type, Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 56. by Application, Southeast Asia Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 57. India Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 58. By Company, India Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 59. by Type, India Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 60. by Application, India Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 61. Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue, 2020-2031, US$ Million
Figure 62. By Company, Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024
Figure 63. by Type, Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 64. by Application, Middle East & Africa Prenatal Second-Generation DNA Sequencing Revenue Market Share, 2024 VS 2031
Figure 65. Research Methodology
Figure 66. Breakdown of Primary Interviews
Figure 67. Bottom-up Approaches
Figure 68. Top-down Approaches
Research Methodology:
Prenatal Second-Generation DNA Sequencing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|